Q1 2019 Holdings
Filed 2019-05-14 | 62 holdings | $22.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $7.2M | 269,000 | 31.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $5.7M | 64,284 | 25.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $3.2M | 33,800 | 13.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $2.5M | 36,500 | 10.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $2.2M | 9,500 | 9.9% |
| Ascendis Pharma A S(ASND) | Sponsored ADR | 04351P101 | $1.6M | 13,800 | 7.2% |
| Celgene Corp(CELG) | COM | 151020104 | $22.2K | 235,522 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $18.1K | 278,284 | 0.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $13.0K | 31,630 | 0.1% |
| Stemline Therapeutics Inc | COM | 85858C107 | $10.2K | 796,245 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $10.0K | 73,641 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $9.4K | 51,122 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.1K | 103,600 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $9.1K | 240,493 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $8.7K | 101,500 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $8.5K | 233,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $7.8K | 25,100 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $7.7K | 475,633 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $7.2K | 151,117 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.1K | 213,061 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $5.8K | 61,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $5.8K | 243,534 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $5.6K | 145,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $5.4K | 33,996 | 0.0% |
| Zogenix Inc | COM | 98978L204 | $5.1K | 93,000 | 0.0% |
| Retrophin Inc | COM | 761299106 | $4.7K | 208,000 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $4.6K | 24,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $4.5K | 60,900 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $3.9K | 47,781 | 0.0% |
| Horizon Pharma Plc | COM | G4617B105 | $3.4K | 128,000 | 0.0% |
| Abiomed Inc(ABMDEUR) | COM | 003654100 | $3.3K | 11,700 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $3.2K | 110,000 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $3.2K | 89,953 | 0.0% |
| Intersect Ent Inc | COM | 46071F103 | $3.1K | 96,000 | 0.0% |
| Amarin Corp Plc | SPONS ADR NEW | 023111206 | $2.8K | 137,000 | 0.0% |
| GW Pharmaceuticals Plc | ADS | 36197T103 | $2.8K | 16,800 | 0.0% |
| Bluebird Bio Inc | COM | 09609G100 | $2.7K | 17,000 | 0.0% |
| Akcea Therapeutics Inc(AKCAEUR) | COM | 00972L107 | $2.1K | 74,608 | 0.0% |
| Radius Health Inc | COM | 750469207 | $2.1K | 105,829 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $2.0K | 60,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $1.8K | 72,500 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $1.7K | 146,653 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $1.6K | 13,800 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $1.6K | 98,482 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $1.6K | 21,700 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $1.6K | 30,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $1.5K | 30,000 | 0.0% |
| Global Blood Therapeutics | COM | 37890U108 | $1.5K | 28,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $1.4K | 30,000 | 0.0% |
| Myriad Genetics inc(MYGN) | COM | 62855J104 | $1.3K | 38,365 | 0.0% |